Oil Palm Phenolics (OPP) Inhibit Pancreatic Cancer Cell Proliferation via Suppression of NF-κB Pathway

被引:0
|
作者
Ji, Xiangming [1 ]
Usman, Anee [1 ]
Razalli, Nurul H. [1 ]
Sambanthamurthi, Ravigadevi [2 ]
Gupta, Smiti V. [1 ]
机构
[1] Wayne State Univ, Dept Nutr & Food Sci, Detroit, MI 48202 USA
[2] Malaysian Palm Oil Board, Bandar Baru Bangi, Selangor, Malaysia
关键词
Pancreatic cancer; NF-kappa B; apoptosis; oil palm phenolics; LUNG-CANCER; DELTA-TOCOTRIENOL; STATISTICS; APOPTOSIS;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Oil palm phenolics (OFF) or Palm Juice (PJ), a water soluble extract from the palm fruit (Elaies guineensis) has been documented to have anti-carcinogenic activities in various cancer types. Materials and Methods: To investigate OFF effects in pancreatic cancer (PaCa) cells, two PaCa cell lines (PANC-I and BxPC-3) were treated with different OFF doses. The anti-proliferative, apoptotic and anti-invasive properties of OFF were evaluated using MTS, cytoplasmic hi stone-DNA fragmentation and matrigel invasive assays, respectively. Results: OFF suppressed PaCa proliferation in a dose-dependent manner. Its anti-invasive effects were validated by decreased expressions of MMP-9 and VEGF. Cell-cycle analysis demonstrated that cells were arrested in the S phase. OFF-induced apoptosis was associated with decrease in survivin and Bcl-XL expressions and increased expression of cleaved caspase-3, caspase-9 and PARP. Conclusion: Overall, our results demonstrate the anti-tumor effects of OFF on PaCa cells, providing initial evidence towards its potential therapeutic use.
引用
收藏
页码:97 / 106
页数:10
相关论文
共 50 条
  • [1] Aconitine induces cell apoptosis in human pancreatic cancer via NF-κB signaling pathway
    Ji, B-L
    Xia, L-P
    Zhou, F-X
    Mao, G-Z
    Xu, L-X
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2016, 20 (23) : 4955 - 4964
  • [2] Bryostatin I inhibits growth and proliferation of pancreatic cancer cells via suppression of NF-κB activation
    Peng, Xiao-Bin
    Wu, Gao-Jue
    Wang, Xiao-Yu
    Tang, Xue-Jun
    Gong, Lei
    TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH, 2016, 15 (10) : 2071 - 2076
  • [3] NF-κB/Rel transcriptional pathway -: Implications in pancreatic cancer
    Algül, H
    Adler, G
    Schmid, RM
    JOURNAL OF GASTROINTESTINAL CANCER, 2002, 31 (1-3) : 71 - 78
  • [4] Optineurin suppression causes neuronal cell death via NF-κB pathway
    Akizuki, Mayumi
    Yamashita, Hirofumi
    Uemura, Kengo
    Maruyama, Hirofumi
    Kawakami, Hideshi
    Ito, Hidefumi
    Takahashi, Ryosuke
    JOURNAL OF NEUROCHEMISTRY, 2013, 126 (06) : 699 - 704
  • [5] NIK is involved in constitutive activation of the alternative NF-κB pathway and proliferation of pancreatic cancer cells
    Nishina, Takashi
    Yamaguchi, Noritaka
    Gohda, Jin
    Semba, Kentaro
    Inoue, Jun-ichiro
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2009, 388 (01) : 96 - 101
  • [6] Calreticulin (CALR)-induced activation of NF-κB signaling pathway boosts lung cancer cell proliferation
    Gao, Fangfang
    Mu, Xiaoqian
    Wu, Huijuan
    Chen, Lijuan
    Liu, Jie
    Zhao, Yanqiu
    BIOENGINEERED, 2022, 13 (03) : 6856 - 6865
  • [7] Targeting the alternative NF-κB pathway in pancreatic cancer: a new direction for therapy?
    Storz, Peter
    EXPERT REVIEW OF ANTICANCER THERAPY, 2013, 13 (05) : 501 - 504
  • [8] Acetylshikonin Inhibits Human Pancreatic PANC-1 Cancer Cell Proliferation by Suppressing the NF-κB Activity
    Cho, Seok-Cheol
    Choi, Bu Young
    BIOMOLECULES & THERAPEUTICS, 2015, 23 (05) : 428 - 433
  • [9] Bufalin inhibits pancreatic cancer by inducing cell cycle arrest via the c-Myc/NF-κB pathway
    Liu, Xia
    Xiao, Xiang-yang
    Shou, Qi-Yang
    Yan, Jun-feng
    Chen, Long
    Fu, Hui-ying
    Wang, Jian-chao
    JOURNAL OF ETHNOPHARMACOLOGY, 2016, 193 : 538 - 545
  • [10] Dihydroartemisinin inhibits angiogenesis in pancreatic cancer by targeting the NF-κB pathway
    Wang, Shuang-Jia
    Sun, Bei
    Cheng, Zhuo-Xin
    Zhou, Hao-Xin
    Gao, Yue
    Kong, Rui
    Chen, Hua
    Jiang, Hong-Chi
    Pan, Shang-Ha
    Xue, Dong-Bo
    Bai, Xue-Wei
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2011, 68 (06) : 1421 - 1430